Loading…

Abstract A089: Role of Vardhamana Pippali Rasayana (VPR) in human breast cancer cells

Serious concerns include delayed diagnosis and adverse side-effects of conventional treatment leading to residual morbidity in Breast cancer (BC) globally. Traditional Indian medicines/herbs via combination of conventional cancer are gaining increasing acceptance worldwide, playing a pivotal role as...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 2024-02, Vol.84 (3_Supplement_1), p.A089-A089
Main Authors: Tripathi, Dr.Richa, Singh, Shivam, Gupta, Subhash, Huddar, VG, Nesari, Tanuja M, Sharma, Ashok
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page A089
container_issue 3_Supplement_1
container_start_page A089
container_title Cancer research (Chicago, Ill.)
container_volume 84
creator Tripathi, Dr.Richa
Singh, Shivam
Gupta, Subhash
Huddar, VG
Nesari, Tanuja M
Sharma, Ashok
description Serious concerns include delayed diagnosis and adverse side-effects of conventional treatment leading to residual morbidity in Breast cancer (BC) globally. Traditional Indian medicines/herbs via combination of conventional cancer are gaining increasing acceptance worldwide, playing a pivotal role as proven by their efficacy evaluation studies. Many plants are known to reduce the cell proliferation and tumor development after their treatment. Vardhamana Pippali Rasayana (VPR), an Ayurvedic herbal preparation of pippali (Piper longum) in gradually increasing and tapering dose is used to treat many cancers without any adverse side-effects. However, its anti-cancer role in breast cancer is not known yet. The present study has explored the cytotoxic and apoptotic effects of VPR in triplicates on human breast cancer (MCF7) and normal breast epithelial (MCF10A) cell lines at different concentrations after extracting piperine in aqueous and hydro-alcoholic soxhlet extract (0.25 to 50 μg/μl). The cytotoxic activity was carried out by MTT assay and results showed that a low IC50 was observed at 3.75 μg/μl of VPR against MCF-7 as compared with normal breast epithelial cells. Detection of apoptotic cells using suitable Annexin V was done and there was a time-dependent increase in percentage of annexin V positive cells upon treatment. The above results indicate that VPR may have a strong anti-cancerous potential. But other functional assays are warranted to validate the efficacy of the drug against breast cancer which are under progress in our laboratory. Citation Format: Dr.Richa Tripathi, Shivam Singh, Subhash Gupta, VG Huddar, Tanuja M Nesari, Ashok Sharma. Role of Vardhamana Pippali Rasayana (VPR) in human breast cancer cells [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Breast Cancer Research; 2023 Oct 19-22; San Diego, California. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_1):Abstract nr A089.
doi_str_mv 10.1158/1538-7445.ADVBC23-A089
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1158_1538_7445_ADVBC23_A089</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1158_1538_7445_ADVBC23_A089</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1158_1538_7445_ADVBC23_A0893</originalsourceid><addsrcrecordid>eNqdj81uwjAQhC1UJNLCK6A9wiHUJhhCbykF9Yiikqu1GEcEOT_ypoe8PViKKs497WhnRvqGsangCyFk_C5kFIeb1Uoukq_sc7eMwoTH2wEL_oyXJz1ir0Q3zrkUXAbslJypdahb8KUPSGtroM4hQ3e5YokVwrFoGrQFpEjY-ccsO6ZzKCq4_j4CcHYGqQWNlTYOtLGWxmyYoyUz6e8bWx_2P7vvULuayJlcNa4o0XVKcOVHKM-nPJ_qRyjPE_27eAd44lAI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Abstract A089: Role of Vardhamana Pippali Rasayana (VPR) in human breast cancer cells</title><source>EZB Electronic Journals Library</source><creator>Tripathi, Dr.Richa ; Singh, Shivam ; Gupta, Subhash ; Huddar, VG ; Nesari, Tanuja M ; Sharma, Ashok</creator><creatorcontrib>Tripathi, Dr.Richa ; Singh, Shivam ; Gupta, Subhash ; Huddar, VG ; Nesari, Tanuja M ; Sharma, Ashok</creatorcontrib><description>Serious concerns include delayed diagnosis and adverse side-effects of conventional treatment leading to residual morbidity in Breast cancer (BC) globally. Traditional Indian medicines/herbs via combination of conventional cancer are gaining increasing acceptance worldwide, playing a pivotal role as proven by their efficacy evaluation studies. Many plants are known to reduce the cell proliferation and tumor development after their treatment. Vardhamana Pippali Rasayana (VPR), an Ayurvedic herbal preparation of pippali (Piper longum) in gradually increasing and tapering dose is used to treat many cancers without any adverse side-effects. However, its anti-cancer role in breast cancer is not known yet. The present study has explored the cytotoxic and apoptotic effects of VPR in triplicates on human breast cancer (MCF7) and normal breast epithelial (MCF10A) cell lines at different concentrations after extracting piperine in aqueous and hydro-alcoholic soxhlet extract (0.25 to 50 μg/μl). The cytotoxic activity was carried out by MTT assay and results showed that a low IC50 was observed at 3.75 μg/μl of VPR against MCF-7 as compared with normal breast epithelial cells. Detection of apoptotic cells using suitable Annexin V was done and there was a time-dependent increase in percentage of annexin V positive cells upon treatment. The above results indicate that VPR may have a strong anti-cancerous potential. But other functional assays are warranted to validate the efficacy of the drug against breast cancer which are under progress in our laboratory. Citation Format: Dr.Richa Tripathi, Shivam Singh, Subhash Gupta, VG Huddar, Tanuja M Nesari, Ashok Sharma. Role of Vardhamana Pippali Rasayana (VPR) in human breast cancer cells [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Breast Cancer Research; 2023 Oct 19-22; San Diego, California. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_1):Abstract nr A089.</description><identifier>ISSN: 1538-7445</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/1538-7445.ADVBC23-A089</identifier><language>eng</language><ispartof>Cancer research (Chicago, Ill.), 2024-02, Vol.84 (3_Supplement_1), p.A089-A089</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Tripathi, Dr.Richa</creatorcontrib><creatorcontrib>Singh, Shivam</creatorcontrib><creatorcontrib>Gupta, Subhash</creatorcontrib><creatorcontrib>Huddar, VG</creatorcontrib><creatorcontrib>Nesari, Tanuja M</creatorcontrib><creatorcontrib>Sharma, Ashok</creatorcontrib><title>Abstract A089: Role of Vardhamana Pippali Rasayana (VPR) in human breast cancer cells</title><title>Cancer research (Chicago, Ill.)</title><description>Serious concerns include delayed diagnosis and adverse side-effects of conventional treatment leading to residual morbidity in Breast cancer (BC) globally. Traditional Indian medicines/herbs via combination of conventional cancer are gaining increasing acceptance worldwide, playing a pivotal role as proven by their efficacy evaluation studies. Many plants are known to reduce the cell proliferation and tumor development after their treatment. Vardhamana Pippali Rasayana (VPR), an Ayurvedic herbal preparation of pippali (Piper longum) in gradually increasing and tapering dose is used to treat many cancers without any adverse side-effects. However, its anti-cancer role in breast cancer is not known yet. The present study has explored the cytotoxic and apoptotic effects of VPR in triplicates on human breast cancer (MCF7) and normal breast epithelial (MCF10A) cell lines at different concentrations after extracting piperine in aqueous and hydro-alcoholic soxhlet extract (0.25 to 50 μg/μl). The cytotoxic activity was carried out by MTT assay and results showed that a low IC50 was observed at 3.75 μg/μl of VPR against MCF-7 as compared with normal breast epithelial cells. Detection of apoptotic cells using suitable Annexin V was done and there was a time-dependent increase in percentage of annexin V positive cells upon treatment. The above results indicate that VPR may have a strong anti-cancerous potential. But other functional assays are warranted to validate the efficacy of the drug against breast cancer which are under progress in our laboratory. Citation Format: Dr.Richa Tripathi, Shivam Singh, Subhash Gupta, VG Huddar, Tanuja M Nesari, Ashok Sharma. Role of Vardhamana Pippali Rasayana (VPR) in human breast cancer cells [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Breast Cancer Research; 2023 Oct 19-22; San Diego, California. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_1):Abstract nr A089.</description><issn>1538-7445</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqdj81uwjAQhC1UJNLCK6A9wiHUJhhCbykF9Yiikqu1GEcEOT_ypoe8PViKKs497WhnRvqGsangCyFk_C5kFIeb1Uoukq_sc7eMwoTH2wEL_oyXJz1ir0Q3zrkUXAbslJypdahb8KUPSGtroM4hQ3e5YokVwrFoGrQFpEjY-ccsO6ZzKCq4_j4CcHYGqQWNlTYOtLGWxmyYoyUz6e8bWx_2P7vvULuayJlcNa4o0XVKcOVHKM-nPJ_qRyjPE_27eAd44lAI</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Tripathi, Dr.Richa</creator><creator>Singh, Shivam</creator><creator>Gupta, Subhash</creator><creator>Huddar, VG</creator><creator>Nesari, Tanuja M</creator><creator>Sharma, Ashok</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20240201</creationdate><title>Abstract A089: Role of Vardhamana Pippali Rasayana (VPR) in human breast cancer cells</title><author>Tripathi, Dr.Richa ; Singh, Shivam ; Gupta, Subhash ; Huddar, VG ; Nesari, Tanuja M ; Sharma, Ashok</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1158_1538_7445_ADVBC23_A0893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tripathi, Dr.Richa</creatorcontrib><creatorcontrib>Singh, Shivam</creatorcontrib><creatorcontrib>Gupta, Subhash</creatorcontrib><creatorcontrib>Huddar, VG</creatorcontrib><creatorcontrib>Nesari, Tanuja M</creatorcontrib><creatorcontrib>Sharma, Ashok</creatorcontrib><collection>CrossRef</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tripathi, Dr.Richa</au><au>Singh, Shivam</au><au>Gupta, Subhash</au><au>Huddar, VG</au><au>Nesari, Tanuja M</au><au>Sharma, Ashok</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Abstract A089: Role of Vardhamana Pippali Rasayana (VPR) in human breast cancer cells</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><date>2024-02-01</date><risdate>2024</risdate><volume>84</volume><issue>3_Supplement_1</issue><spage>A089</spage><epage>A089</epage><pages>A089-A089</pages><issn>1538-7445</issn><eissn>1538-7445</eissn><abstract>Serious concerns include delayed diagnosis and adverse side-effects of conventional treatment leading to residual morbidity in Breast cancer (BC) globally. Traditional Indian medicines/herbs via combination of conventional cancer are gaining increasing acceptance worldwide, playing a pivotal role as proven by their efficacy evaluation studies. Many plants are known to reduce the cell proliferation and tumor development after their treatment. Vardhamana Pippali Rasayana (VPR), an Ayurvedic herbal preparation of pippali (Piper longum) in gradually increasing and tapering dose is used to treat many cancers without any adverse side-effects. However, its anti-cancer role in breast cancer is not known yet. The present study has explored the cytotoxic and apoptotic effects of VPR in triplicates on human breast cancer (MCF7) and normal breast epithelial (MCF10A) cell lines at different concentrations after extracting piperine in aqueous and hydro-alcoholic soxhlet extract (0.25 to 50 μg/μl). The cytotoxic activity was carried out by MTT assay and results showed that a low IC50 was observed at 3.75 μg/μl of VPR against MCF-7 as compared with normal breast epithelial cells. Detection of apoptotic cells using suitable Annexin V was done and there was a time-dependent increase in percentage of annexin V positive cells upon treatment. The above results indicate that VPR may have a strong anti-cancerous potential. But other functional assays are warranted to validate the efficacy of the drug against breast cancer which are under progress in our laboratory. Citation Format: Dr.Richa Tripathi, Shivam Singh, Subhash Gupta, VG Huddar, Tanuja M Nesari, Ashok Sharma. Role of Vardhamana Pippali Rasayana (VPR) in human breast cancer cells [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Breast Cancer Research; 2023 Oct 19-22; San Diego, California. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_1):Abstract nr A089.</abstract><doi>10.1158/1538-7445.ADVBC23-A089</doi></addata></record>
fulltext fulltext
identifier ISSN: 1538-7445
ispartof Cancer research (Chicago, Ill.), 2024-02, Vol.84 (3_Supplement_1), p.A089-A089
issn 1538-7445
1538-7445
language eng
recordid cdi_crossref_primary_10_1158_1538_7445_ADVBC23_A089
source EZB Electronic Journals Library
title Abstract A089: Role of Vardhamana Pippali Rasayana (VPR) in human breast cancer cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T23%3A53%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Abstract%20A089:%20Role%20of%20Vardhamana%20Pippali%20Rasayana%20(VPR)%20in%20human%20breast%20cancer%20cells&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=Tripathi,%20Dr.Richa&rft.date=2024-02-01&rft.volume=84&rft.issue=3_Supplement_1&rft.spage=A089&rft.epage=A089&rft.pages=A089-A089&rft.issn=1538-7445&rft.eissn=1538-7445&rft_id=info:doi/10.1158/1538-7445.ADVBC23-A089&rft_dat=%3Ccrossref%3E10_1158_1538_7445_ADVBC23_A089%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-crossref_primary_10_1158_1538_7445_ADVBC23_A0893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true